NEWS
HONEYWELL INTRODUCES LIQUID FLOW SENSING SOLUTION TO IMPROVE MEDICATION DELIVERY FOR PATIENTS AND CLINICIANS
Honeywell introduced a new liquid flow sensing platform designed and developed to increase the accuracy of dosing liquid medications and improve the treatment process for patients . With uses across multiple areas – from medical fluid management to wearable drug delivery and in vitro diagnostics – Honeywell ’ s new sensing solution has the potential to give clinicians back time in their day and enable patients to receive more personalised therapies so they can return home from the hospital sooner . The development of digital solutions that use advanced sensing capabilities to improve operations for the healthcare sector also supports Honeywell ’ s portfolio alignment to three powerful megatrends , including automation .
“ Healthcare is facing tremendous challenges today with a stretched workforce and legacy equipment that requires frequent calibration and maintenance ,” said Sarah Martin ,
President of Honeywell Sensing Solutions . “ By creating digital technologies that can lighten the load for healthcare workers , we can help patients have a better treatment experience , reduce needed intervention with equipment and ultimately further move healthcare into the future .”
When administering medications to patients , many other technologies available today are prone to errors or need frequent intervention . For example , if a patient receiving intravenous ( IV ) treatment moves their arm or knocks into the machine , a clinician must often spend time readjusting the equipment so it can deliver the right amount of medication .
By using thermopile technology to calculate flow rate and integrating other sensing technologies into the platform , Honeywell ’ s new liquid flow platform enables healthcare equipment to maintain highly accurate medication flow without being susceptible to the movement errors that would otherwise require intervention . With Honeywell ’ s technology , patients can now receive consistent and more effective treatment , freeing up time for clinicians and helping reduce wasted medication , a concern for many costly drugs today .
CARDINAL HEALTH LAUNCHES NEW ORDERING PORTAL FOR CELL AND GENE THERAPIES
Cardinal Health has announced the launch of Advanced
Therapy Connect , a first-to-market unified ordering portal for cell and gene therapies , through its Advanced Therapy Solutions business . Ordering cell and gene therapies has historically required healthcare providers to log into separate product platforms with disparate reporting structures and processes for invoicing and payment .
“ A major challenge associated with cell and gene therapy ordering has been that each product has its own portal with unique log-in information , which creates a burdensome and complex process for healthcare providers ,” said Fran Gregory , VP , Emerging Therapies . “ We ’ re excited to bring this solution to market and truly simplify the ordering process for our customers so they can focus on patient care .”
Advanced Therapy Connect enables providers at treatment sites to order all available in-network cell and gene products within a single platform , reducing the administrative burden for healthcare providers . Developed with the help of provider feedback , Advanced Therapy Connect reduces manual errors and optimises access to cell and gene therapies .
Advanced Therapy Solutions works with manufacturers to commercialise cell and gene therapies , with services that span regulatory consulting , order-to-cash management , patient support services and market access strategy , as well as storage , shipping and distribution solutions through our market leading 3PL Services and Packaging Solutions business . Advanced Therapy Connect is the latest example of Cardinal Health ’ s continued commitment to investing in infrastructure and solutions enabling improved patient access to cell and gene therapies .
6 www . intelligenthealth . tech